*  UC Berkeley Cancer Research Lab » June is Cancer Immunotherapy Month
June is Cancer Immunotherapy Month. June 1st, 2015. The UC Berkeley Cancer Research Lab is joining the Cancer Research ... The Cancer Research Laboratory (CRL) at UC Berkeley has played a key role in the development of novel cancer immunotherapies. ... and led to the revitalization of the whole concept of immunotherapy (see The Story Of Ipilimumab). More recently the work of ... Institute to promote June as Cancer Immunotherapy Month.. ...
  http://crl.berkeley.edu/2015/06/01/june-is-cancer-immunotherapy-month/
*  Advances in Combination Tumor Immunotherapy | Frontiers Research Topic
The purpose of this Research Topic is to highlight recent advances in combination tumor immunotherapy and provide insight into ... Having established this unique capacity of immunotherapy to mediate such durable melanoma tumor rejections, the focus of the ... This trial demonstrated the feasibility and potential therapeutic efficacy of combination immunotherapy for the treatment of ... Recent clinical studies have highlighted the therapeutic efficacy of cancer immunotherapy, such as T cell immune checkpoint ...
  https://www.frontiersin.org/research-topics/2886/advances-in-combination-tumor-immunotherapy
*  RAG1 | Cancer Genetics Web
In this report, we show the relevance and opportunities of this model to study immunotherapy for human NBL. Similar to human ... based immunotherapy, result in a favorable outcome in around only half of the patients with advanced disease. To improve this, ... and have great potential for use as immunotherapy against malignant transformation overexpressing WT1. ...
  http://www.cancerindex.org/geneweb/RAG1.htm
*  Kidney Disease Treatment www.kidney-support.org: Immunotherapy on Treating Kidney Disease
D, Immunotherapy have the characteristic of low immunogenicity. As the Immunotherapy are still in the original stage and it is ... The principle of Immunotherapy on treating kidney dieseases:. As we know, Immunotherapy have the proficiency of multiple- ... So Immunotherapy can regenerate large quantity of offspring.. B, Immunotherapy can restrain the proliferation and immune ... The properties and puperiorities of Immunotherapy on treat the kidney diseases.. A, Immunotherapy have the strong proficiency ...
  http://kidneytreatmentcn.blogspot.com/2016/04/immunotherapy-on-treating-kidney-disease.html
*  2017 Forecast - cancer immunotherapies Global Market, Industry Size, Share, Analysis and Opportunities to 2023. | Market...
Cancer Immunotherapy has brought an unprecedented change in the global cancer therapies market. Cancer immunotherapy can be ... Over the past few years, cancer immunotherapies have generated new waves of optimism in the global oncology market, unveiling ... The key factors driving the global cancer immunotherapy's market are rising incidences of cancer, minimal or no side effects ... 2017 Forecast - cancer immunotherapies Global Market, Industry Size, Share, Analysis and Opportunities to 2023. ...
  http://beforeitsnews.com/market-research-reports/2017/03/2017-forecast-cancer-immunotherapies-global-market-industry-size-share-analysis-and-opportunities-to-2023-258.html
*  Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis - Full Text View - ClinicalTrials...
A history of allergen immunotherapy in the previous 10 years, or in the previous 3 years for pre-seasonal immunotherapy ... At present, the efficacy of immunotherapy (peptide or otherwise) can only be established at the conclusion of therapy. The aim ... Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis. Further study details as ... Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis. This study has been completed. ...
  https://clinicaltrials.gov/ct2/show/NCT01383590
*  UC Berkeley Cancer Research Lab » CEND/IVRI Symposium on Immunotherapy at UC Berkeley
CEND/IVRI Symposium on Immunotherapy at UC Berkeley. March 7th, 2016. The CRL is joining forces with two campus organizations ... The common focus is to discuss the potential of immunotherapy to address both diseases. ... to sponsor an exciting new Symposium at UC Berkeley on Immunotherapy.. The CRL will join the Henry Wheeler Center for Emerging ...
  http://crl.berkeley.edu/2016/03/07/cendivri-symposium-on-immunotherapy-at-uc-berkeley/
*  Post-Doctoral Scientist, Sotomayor Lab
His primary area of research is immunobiology and immunotherapy of B-cell malignancies, with special emphasis on the design of ...
  https://www.gwu.jobs/postings/47893
*  Cancer Immunotherapy & Biofluid Biopsies 2016
... brings together the key opinion leaders in the immunotherapy and tumor immunology ... Cancer Immunotherapy represents a portfolio of approaches aimed at deploying the immune system against tumor targets in vivo. ... Leader, Cancer Immunotherapy, Foundation Medicine. Gordon Freeman. Professor of Medicine, Dana-Farber Cancer Institute, Harvard ... suitable for immunotherapies.. Presentations from researchers and clinician-scientists at this conference discuss the most ...
  http://selectbiosciences.com/pastConferences/pastconferenceID.aspx?conf=CIBB2016
*  Cancer Immunotherapy Market Sales Segmentation with Manufacturers, Types, Application and Growth Analysis by Regions from 2016...
Global Cancer Immunotherapy Market research report is a professional and in-depth study on the current state of the Cancer ... Cancer Immunotherapy Market is expected to witness growth of international market with respect to advancements and innovations ... The global Cancer Immunotherapy market consumption for major regions is given. Additionally, type wise and application wise ... Also, the Cancer Immunotherapy market growth in various regions and R&D status are also covered. ...
  http://www.abnewswire.com/pressreleases/cancer-immunotherapy-market-sales-segmentation-with-manufacturers-types-application-and-growth-analysis-by-regions-from-2016-to-2021_83165.html
*  Study suggests immunotherapy may help overcome trastuzumab-resistance in breast cancer - EPM Magazine
... have suggested that immunotherapy may help to overcome trastuzumab-resistant breast cancer. ... PANACEA study immunotherapy combination trastuzumab breast cancer International Breast Cancer Study Group (IBCSG) HER2-positive ... A significant amount of preclinical and correlative clinical data suggest that such cases could be amenable to immunotherapy." ... Home News Study suggests immunotherapy may help overcome trastuzumab-resistance in breast cancer ...
  https://www.epmmagazine.com/news/study-suggests-immunotherapy-may-help-overcome-trastuzumab-r/
*  Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses | JEM
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. Byron H. Kwan, Eric F. Zhu, Alice Tzeng, ... Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. View ORCID ProfileByron H. Kwan, Eric F. ... Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. Curr. Opin. Immunol. 25:268-276 ... Raising the bar: the curative potential of human cancer immunotherapy. Sci. Transl. Med. 4:127ps8. doi:10.1126/scitranslmed. ...
  http://jem.rupress.org/content/early/2017/05/03/jem.20160831
*  PSRC - TUMOR-INDUCED, DYSFUNCTIONAL CD8+ T CELLS: IMPLICATIONS FOR CANCER IMMUNOTHERAPY
TUMOR-INDUCED, DYSFUNCTIONAL CD8+ T CELLS: IMPLICATIONS FOR CANCER IMMUNOTHERAPY. Presenter: Brian Gastman. Co-Authors: ... as well as years of immunotherapy development, truly effective immune-based therapies remain out of reach. We have previously ... highlight a novel pathway of immunoregulation in cancer and could inform the development of more effective immunotherapies. ...
  http://www.ps-rc.org/meeting/abstracts/2013/36.cgi
*  Step 11: Immunotherapy | Nicklaus Children's Hospital
Step 11: Immunotherapy *NO TITLE. Immunotherapy is like a vaccination against your allergies. Vaccine shots are to prevent ... Risks involved with immunotherapy. Since immunotherapy involves the injection of something that you are allergic to, there is a ... With the advice of your allergist, you can decide if immunotherapy is right for you. Do the benefits of immunotherapy outweigh ... You should not receive immunotherapy if you are taking beta-blocker medication. Beta-blockers counteract the effects of ...
  https://www.nicklauschildrens.org/care-guides/step-11-immunotherapy
*  Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD). - Full Text View - ClinicalTrials.gov
Drug: HAART + Immunotherapy Patients assigned to this arm will receive Trizivir + Kaletra + cyclosporin A during the first two ... Experimental: HAART + Immunotherapy Patients assigned to this arm will receive HAART plus cyclosporin A during the first two ...
  https://clinicaltrials.gov/show/NCT00979706?order=260
*  Understanding Immunotherapy and Cancer Immunotherapy Archives »
Tag: Understanding Immunotherapy and Cancer Immunotherapy. Understanding Immunotherapy and Cancer Immunotherapy. *Health ... Understanding Immunotherapy Immunotherapy is a broad category of anti-cancer therapies that use the body's immune system to ... What Is Cancer Immunotherapy Immunotherapy is treatment that uses certain parts of a person's immune system to fight ...
  http://selectoday.com/tag/understanding-immunotherapy-and-cancer-immunotherapy/
*  World Immunotherapy Congress USA 2017 - ADC Review ADC Review
That's why World Immunotherapy Congress is coming to the USA after an acclaimed launch in Europe. This inaugural event will ... Co-located with the Americas Antibody Congress, Immunotherapy World Congress USA features 2 days of in-depth case studies and ... The demand for innovation in immunotherapy can only grow, and new breakthroughs are needed if success rates are to continue. ... government and academia to build on the development and commercialization of new immunotherapy treatments. ...
  https://adcreview.com/events/world-immunotherapy-congress-usa-2017/
*  Cancer Vaccines : Pharmaceuticals : UK
13:30 Individualised mRNA cancer immunotherapy. Ludwig Heesen, Project Manager, BioNTech AG. View Bio. Ludwig Heesen studied ... Stephanie McArdle is at the head of T-cell vaccine immunotherapy, which is mainly focused on the validation of novel ... Stephanie McArdle is at the head of T-cell vaccine immunotherapy, which is mainly focused on the validation of novel ... Alfredo is CEO of Nouscom AG, a biotech company dedicated to the development of next generation immunotherapies to beat cancer ...
  http://www.smi-online.co.uk/pharmaceuticals/uk/conference/cancer-vaccines
*  HON - News : Immune-Based Therapy Shows Early Promise Against MS
The approach is known as "adoptive" immunotherapy, where a patient's own immune system T cells are genetically tweaked to fight ...
  http://www.hon.ch/News/HSN/721885.html
*  Immunotherapy
... About Immunotherapy. Immunotherapy, also known as targeted therapy or biotherapy, is a promising new cancer ... Types of Immunotherapy. The aim of immunotherapy is to boost the immune system through the use of:. *active therapies, which ... Non-specific immunotherapies. Unlike cancer vaccines, which are very specific to certain cells, non-specific immunotherapies ... Several types of immunotherapies from these two classes currently are in use or being studied by researchers, including:. ...
  http://kidshealth.org/en/parents/immunotherapy.html?view=ptr&WT.ac=p-ptr
*  Cancer Immunotherapy
Get information about the different types of immunotherapy and the types of cancer they are used to treat. ... Immunotherapy is treatment that uses your body's own immune system to help fight cancer. ... Cancer Immunotherapy. Immunotherapy is treatment that uses your body's own immune system to help fight cancer. Get information ... about the different types of immunotherapy and the types of cancer they are used to treat. ...
  https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy.html
*  Venom Immunotherapy | Encyclopedia.com
Other products used in apitherapy include bee pollen and royal jelly . Source for information on Venom Immunotherapy: Gale ... Venom immunotherapy Definition Venom immunotherapy is the process of injecting venom to treat various conditions. The most ... Venom immunotherapy. Definition. Venom immunotherapy is the process of injecting venom to treat various conditions. The most ... Before beginning venom immunotherapy, a person should be tested for allergies . If a relative or friend plans to help with the ...
  https://www.encyclopedia.com/medicine/encyclopedias-almanacs-transcripts-and-maps/venom-immunotherapy
*  Immunology and Immunotherapy | SpringerLink
Lode HN, Reisfeld RA (2000) Targeted cytokines for cancer immunotherapy. Immunol Res 21:279-288CrossRefPubMedGoogle Scholar ... 2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22-32CrossRefPubMed ... 1999) Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo. ... 2002) Targeted alpha particle immunotherapy for myeloid leukemia. Blood 100:1233-1239PubMedGoogle Scholar ...
  https://link.springer.com/chapter/10.1007/3-540-26616-X_14
*  immunotherapy | Cancer.Net
CAR T-Cell Immunotherapy: The 2018 Advance of the Year. Language English ... ASCO and NCCN have worked together to help clinicians and patients identify and treat the side effects of immunotherapy before ... ASCO Annual Meeting 2018: Less Treatment Needed for Some Patients With Breast Cancer and Kidney Cancer, Immunotherapy for Non- ... an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people ...
  https://www.cancer.net/tags/immunotherapy
*  immunotherapy | Research!America
The more researchers know about how different therapies work and for whom they work, the faster they can make progress in finding treatments, said Dr. William Nelson, director of Johns Hopkins Kimmel Cancer Center during a panel discussion on March 8 about precision medicine moderated by The Washington Post's Laurie McGinley. The discussion was part of Johns Hopkins Medicine's On the Road to Precision Medicine Health Care Leader Series , which explores topics of cost, communication, research, and health care delivery in relation to precision medicine. Regarding concerns that the drug approval process is too lengthy, Nelson said that the efficiency achieved by focusing on creating targeted ...
  http://www.researchamerica.org/blog-tags/immunotherapy